Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Peru $3 billion global bond offering
We advised Peru on its global bond offering
Allegro MicroSystems repurchase of 39 million shares held by Sanken Electric
We advised Allegro on the share repurchase, equity offering and incremental and refinancing credit facilities
Morgan Stanley $1 billion preferred stock offering
We advised Morgan Stanley on its SEC-registered offering
Bansk Group $1.5 billion going-private acquisition of PetIQ
We are advising Bansk Group on the transaction
Revolution Medicines $500 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
AC Immune $80 million at-the-market offering
We advised AC Immune on the offering
Adecoagro cash tender offer
We advised the company on the tender offer
Southwest Gas Holdings $340 million at-the-market offering
The shares are listed on the New York Stock Exchange
SGH $175 million convertible notes offering and capped call transactions
The 2% convertible senior notes are due 2030
MicroStrategy $2 billion at-the-market offering
The stock is listed on the Nasdaq Global Select Market